Concurrent chemotherapy for T4 classification nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy. - Wikidata - wikimedia - TriplyDB

Concurrent chemotherapy for T4 classification nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.

Concurrent chemotherapy for T4 classification nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.

http://www.wikidata.org/entity/Q35154741

about

Chemoradiotherapy enhanced the efficacy of radiotherapy in nasopharyngeal carcinoma patients: a network meta-analysis Role of regenerating gene IA expression on local invasion and survival in nasopharyngeal carcinoma.

P2860

Q33889391-E9F019E0-59F8-495E-A825-DF105EF9E7B0 Q45952864-DE8DF471-09A1-43C2-B6C7-2640345CA18A

P2860

Concurrent chemotherapy for T4 classification nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.

http://www.wikidata.org/entity/Q35154741

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Concurrent chemotherapy for T4 ...... ensity-modulated radiotherapy.

@ast

Concurrent chemotherapy for T4 ...... ensity-modulated radiotherapy.

@en

type

label

Concurrent chemotherapy for T4 ...... ensity-modulated radiotherapy.

@ast

Concurrent chemotherapy for T4 ...... ensity-modulated radiotherapy.

@en

prefLabel

Concurrent chemotherapy for T4 ...... ensity-modulated radiotherapy.

@ast

Concurrent chemotherapy for T4 ...... ensity-modulated radiotherapy.

@en

P1433

Q35154741-308DDB1B-551B-4077-AC68-1C256D12A454

P1476

Q35154741-35B2C46C-0F1A-4953-BEB5-741C590FCBFC

P2093

Q35154741-0221FC5E-91E1-4E37-AA70-2723239F0568

Q35154741-0E066229-6A52-4396-802E-C64E6C1B48A6

Q35154741-2004C14F-1787-4FB0-B59B-AB541981C6B5

Q35154741-2DD7FDF5-4779-4AA9-B637-ACFED78F7962

Q35154741-407179AE-680C-4222-9ABB-ADA9F01F735C

Q35154741-4D1E0771-1F8E-4CC8-993C-1DE404894DEE

Q35154741-9A471859-FC98-46B6-8A04-626949BBA345

Q35154741-AC4A6037-BB66-4D13-A63E-8FB84426B189

Q35154741-B04AAFEE-EF96-48FE-8EF9-DA951BE12B87

Q35154741-BDC76F46-0901-4DEB-9A22-ED31CE4A22C7

P2860

Q35154741-0730F614-EA44-4290-ADCF-519AB8A7A9EF

Q35154741-1236BB03-BC8F-4CB1-AB03-70E71689E674

Q35154741-1E3191A0-FD4C-4F8A-93F0-DD25FB5C7E26

Q35154741-35D3A7D9-8207-4F1A-8ACE-D8F901FAF600

Q35154741-45A467AE-52A4-42AF-ABA6-E5F0A1BBC1DE

Q35154741-580821BB-24B9-4F27-8C2C-2ED9CF5903AD

Q35154741-6518E001-633B-4574-A6B3-0F9DDEB18B5F

Q35154741-7AE6D7AE-4D51-4AA5-8365-0B73FEA2D402

Q35154741-82BBACD0-77F2-46A5-9404-317F4B3AA168

Q35154741-8CC04C02-3265-4380-8CB6-3FC5DB5121B0

P304

Q35154741-105475E2-7EB7-4567-A23A-E79EDAAF2234

P31

Q35154741-9B36BD0C-7A9D-4292-A84A-EAE8B6D755D8

P356

Q35154741-0D511858-F2DA-4570-8D98-1CF35EA62E58

P407

Q35154741-F261EB08-8EDE-41CB-9183-0D6DC5AD647E

P433

Q35154741-540E3410-71DA-4D73-AC66-17D6B9D9D7D9

P478

Q35154741-259B0091-6EA0-4A78-8F61-C8FFE26980F6

P577

Q35154741-244FB223-DCF3-40D0-8F67-98988C7E043F

P5875

Q35154741-895443AF-0DF3-42A6-9E36-9263BE3A68E2

P698

Q35154741-526C5C14-5355-4589-808B-DFF7765ADF1A

P932

Q35154741-DFD001D0-EBD1-4291-8720-10E4CE292E17

P356

JOURNAL.PONE.0119101

P1433

P1476

Concurrent chemotherapy for T4 ...... ensity-modulated radiotherapy.

@en

P2093

Cai-neng Cao

http://www.w3.org/2001/XMLSchema#string

Guo-zhen Xu

http://www.w3.org/2001/XMLSchema#string

Jian-ping Xiao

http://www.w3.org/2001/XMLSchema#string

Jing-wei Luo

http://www.w3.org/2001/XMLSchema#string

Jun-lin Yi

http://www.w3.org/2001/XMLSchema#string

Kai Wang

http://www.w3.org/2001/XMLSchema#string

Li Gao

http://www.w3.org/2001/XMLSchema#string

Shi-ping Zhang

http://www.w3.org/2001/XMLSchema#string

Su-yan Li

http://www.w3.org/2001/XMLSchema#string

Xiao-dong Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients.

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.

Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.

Treatment outcome of cisplatin-based concurrent chemoradiotherapy in the patients with locally advanced nasopharyngeal cancer.

High-grade acute organ toxicity as positive prognostic factor in adjuvant radiation and chemotherapy for locally advanced head and neck cancer.

Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma.

Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities.

Controversies in the systemic treatment of nasopharyngeal carcinoma.

Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience.

Update report of nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy and hypothesis of the optimal margin.

P304

e0119101

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0119101

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273326085

http://www.w3.org/2001/XMLSchema#string

P698

25747589

http://www.w3.org/2001/XMLSchema#string

P932

4352046

http://www.w3.org/2001/XMLSchema#string